Preventing Infectious Complications of Immunomodulation in COVID-19 in Foreign-Born Patients

Immunomodulating therapies for COVID-19 may carry risks of reactivating latent infections in foreign-born people. We conducted a rapid review of infection-related complications of immunomodulatory therapies for COVID-19. We convened a committee of specialists to formulate a screening and management...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohareb, Amir M., Rosenberg, Jacob M., Bhattacharyya, Roby P., Kotton, Camille N., Chu, Jacqueline T., Jilg, Nikolaus, Hysell, Kristen M., Albin, John S., Sen, Pritha, Bloom, Seth M., Schiff, Abigail E., Zachary, Kimon C., Letourneau, Alyssa R., Kim, Arthur Y., Hurtado, Rocio M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218971/
https://www.ncbi.nlm.nih.gov/pubmed/34159495
http://dx.doi.org/10.1007/s10903-021-01225-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218971/
https://www.ncbi.nlm.nih.gov/pubmed/34159495
http://dx.doi.org/10.1007/s10903-021-01225-4

Ejemplares similares